If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Launch Optimization
28 Info Graphics
11 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Download FREE Excerpt
To return to the study abstract to purchase the full study - click here
This excerpt includes research findings and metrics from document #5573 "Maximizing the Impact of Medical Affairs in Product Launch: Timeline, Resources, and Preparedness".
Pharmaceutical; Consumer Products; Biopharmaceutical; Health Care; Biotech; Clinical Research; Laboratories; Medical Device; Chemical; Diagnostic
Novartis; Clovis Oncology; Merck KGaA; Imbrium Therapeutics; AbbVie; Servier; Sanofi; Dermira; AstraZeneca; Exelixis ; Shire; Curis; Merck; Fidia; Boehringer Ingelheim; Medacta; Santen; EMD Serono; Takeda Pharmaceuticals; cipla; Daiichi Sankyo; Sandoz; Eisai; Vifor Pharma; Alcon; Bausch Health; GE Healthcare; Sanofi Genzyme; Alkermes; Lundbeck; Merz Pharma; Zydus; Torrent Pharmaceuticals Ltd.; Taiho Oncology; Alnylam Pharmaceuticals; Grifols; AcelRx; Vertex Pharmaceuticals; Gedeon Richter ; Celgene; Crescendo Bioscience; Orchard Therapeutics; GRAIL
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.